zirconium has been researched along with singlet oxygen in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Choi, KM; Kwon, W; Ryu, U; Yoo, J | 1 |
Dong, YB; Guan, Q; Li, YA; Xin, YB; Zhou, LL; Zhou, Y | 1 |
Cong, H; Wang, XS; Zeng, JY; Zeng, X; Zhang, M; Zhang, XZ; Zou, MZ | 1 |
Fang, W; Guo, C; Jin, Y; Ma, W; Wang, X; Wang, Z; Wu, X | 1 |
4 other study(ies) available for zirconium and singlet oxygen
Article | Year |
---|---|
Tailoring Nanocrystalline Metal-Organic Frameworks as Fluorescent Dye Carriers for Bioimaging.
Topics: Drug Carriers; Drug Stability; Fluorescent Dyes; Glycosylation; Hep G2 Cells; Humans; Metal-Organic Frameworks; Microscopy, Confocal; Nanoparticles; Oxazines; Particle Size; Photosensitizing Agents; Porosity; Rhodamines; Singlet Oxygen; Zirconium | 2017 |
One-Pot Synthetic Approach toward Porphyrinatozinc and Heavy-Atom Involved Zr-NMOF and Its Application in Photodynamic Therapy.
Topics: Antineoplastic Agents; Drug Stability; Hep G2 Cells; Humans; Light; Luminescence; Metal-Organic Frameworks; Metalloporphyrins; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Singlet Oxygen; Zinc; Zirconium | 2018 |
π-Extended Benzoporphyrin-Based Metal-Organic Framework for Inhibition of Tumor Metastasis.
Topics: Animals; Antineoplastic Agents; Apoptosis; B7-H1 Antigen; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Heterografts; Humans; Immunotherapy; Metal-Organic Frameworks; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Metastasis; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Porphyrins; Programmed Cell Death 1 Receptor; Singlet Oxygen; Tissue Distribution; Tumor Microenvironment; Zirconium | 2018 |
Construction of a nanotheranostic system Zr-MOF@PPa/AF@PEG for improved photodynamic therapy effects based on the PDT‑oxygen consumption and hypoxia sensitive chemotherapeutic drug.
Topics: Animals; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Chlorophyll; Drug Liberation; Female; Flavonoids; Humans; Metal-Organic Frameworks; Mice; Mice, Inbred BALB C; Nanocomposites; Neoplasms; Photochemotherapy; Polyethylene Glycols; Singlet Oxygen; Theranostic Nanomedicine; Tumor Microenvironment; Zirconium | 2021 |